Adjuvant corneal crosslinking to prevent hyperopic LASIK regression
Open Access
- 1 March 2013
- journal article
- Published by Informa UK Limited in Clinical Ophthalmology
- Vol. ume 7, 637-641
- https://doi.org/10.2147/opth.s39796
Abstract
Adjuvant corneal crosslinking to prevent hyperopic LASIK regression Ioannis M Aslanides, Achyut N MukherjeeEmmetropia Mediterranean Eye Clinic, Heraklion, Crete, GreecePurpose: To report the long term outcomes, safety, stability, and efficacy in a pilot series of simultaneous hyperopic laser assisted in situ keratomileusis (LASIK) and corneal crosslinking (CXL).Method: A small cohort series of five eyes, with clinically suboptimal topography and/or thickness, underwent LASIK surgery with immediate riboflavin application under the flap, followed by UV light irradiation. Postoperative assessment was performed at 1, 3, 6, and 12 months, with late follow up at 4 years, and results were compared with a matched cohort that received LASIK only.Results: The average age of the LASIK-CXL group was 39 years (26–46), and the average spherical equivalent hyperopic refractive error was +3.45 diopters (standard deviation 0.76; range 2.5 to 4.5). All eyes maintained refractive stability over the 4 years. There were no complications related to CXL, and topographic and clinical outcomes were as expected for standard LASIK.Conclusion: This limited series suggests that simultaneous LASIK and CXL for hyperopia is safe. Outcomes of the small cohort suggest that this technique may be promising for ameliorating hyperopic regression, presumed to be biomechanical in origin, and may also address ectasia risk.Keyword: CXLKeywords
This publication has 13 references indexed in Scilit:
- Long-term safety and efficacy follow-up of prophylactic higher fluence collagen cross-linking in high myopic laser-assisted in situ keratomileusisClinical Ophthalmology, 2012
- Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for hyperopia correctionCochrane Database of Systematic Reviews, 2012
- Safety and efficacy of collagen crosslinking for the treatment of keratoconusExpert Opinion on Drug Safety, 2010
- Differences in the early biomechanical effects of hyperopic and myopic laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2010
- Risk Assessment for Ectasia after Corneal Refractive SurgeryOphthalmology, 2008
- Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2007
- Analysis of ectasia after laser in situ keratomileusis: Risk factorsJournal of Cataract & Refractive Surgery, 2007
- Biomechanics and wound healing in the corneaExperimental Eye Research, 2006
- Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconusAmerican Journal of Ophthalmology, 2003
- Corneal ectasia induced by laser in situ keratomileusisJournal of Cataract & Refractive Surgery, 2001